Download: PDF RTF XML Booklet: Review (0) Retrieve Add item
EPHA Operating Grant Proposal 2016 SGA [EPHA SGA 2016] [709876] - Operating Grant
Agriculture policy (food, alcohol, tobacco) and NCDs by lead EPHA

Start month:1 - End month: 12

Develop a vision of a coherent sustainable food policy to improve public health outcomes across Europe, including e.g.
- Integrate public health protection and improvement in EU Food and Agriculture p...
Develop a vision of a coherent sustainable food policy to improve public health outcomes across Europe, including e.g.
- Integrate public health protection and improvement in EU Food and Agriculture policies; Promote transition towards sustainable diets.
- Secure European policy action to reduce societal impacts of alcohol;
- Adoption of EU legislation to ban transfats;
- EU objectives on Diet, Obesity and Nutrition become SMART, with measurable positive health impacts;
- Propose improvements for review of Tobacco Products Directive.

EU Semester for Health by lead EPHA

Start month:1 - End month: 12

- Secure appropriate consideration of the public health impacts of the European Semester (annual) Country Specific Recommendations.
- Higher priority for Prevention and Promotion measures, increase av...
- Secure appropriate consideration of the public health impacts of the European Semester (annual) Country Specific Recommendations.
- Higher priority for Prevention and Promotion measures, increase average share of national spending above 3%

Healthy Trade policy by lead EPHA

Start month:1 - End month: 12

To guarantee a high level of protection for public health and to mainstream health throughout trade agreements by enshrining the right to regulate to protect and improve public health, following the p...
To guarantee a high level of protection for public health and to mainstream health throughout trade agreements by enshrining the right to regulate to protect and improve public health, following the precautionary principle.
Public Health and Research in the EU budget by lead EPHA

Start month:1 - End month: 12

Increase the share of spending in the EU Budget (MFF 2020) on health and particularly on prevention and promotion, including Research and Development programme (Horizon2020 follow-up). Deliver timely ...
Increase the share of spending in the EU Budget (MFF 2020) on health and particularly on prevention and promotion, including Research and Development programme (Horizon2020 follow-up). Deliver timely and relevant evidence on key policy questions to European decision-makers, also enhancing EPHA’s credibility and reputation.

Fair and Universal Access to Medicines by lead EPHA

Start month:1 - End month: 12

Raise awareness amongst decision-makers of current and future challenges to accessibility and affordability and appropriate use of medicines and potential policy measures to ensure universal access an...
Raise awareness amongst decision-makers of current and future challenges to accessibility and affordability and appropriate use of medicines and potential policy measures to ensure universal access and reduce health inequalities;
Integrate the public health view in policy discussions, including highlighting the importance of access across the lifespan for all ages and vulnerable groups;
Increase transparency of all EU decisions in relation to pharmaceuticals.

Action on Antimicrobial Resistance by lead EPHA

Start month:1 - End month: 12

Develop policy recommendations and advocate for more effective follow-up of the EU AMR Action Plan, particularly preventive action.
Inclusive e- and m-health by lead EPHA

Start month:1 - End month: 12

Harness public health/prevention potential of e-health and ensure concerns on inclusion, equity and access are well addressed in e-/m-health policies and programmes.
Health Systems Performance Assessment by lead EPHA

Start month:1 - End month: 12

Monitor progress on HSPA and indicators, particularly regarding prevention, report back to members and secure opportunities for consultation as appropriate.
Organisational Development: Function, effectiveness and governance by lead EPHA

Start month:1 - End month: 12

Increase capacity of public health NGOs to undertake coordinated EU advocacy on key priorities, especially for underrepresented communities and groups.
Improve visibility of EPHA messages: appear more...
Increase capacity of public health NGOs to undertake coordinated EU advocacy on key priorities, especially for underrepresented communities and groups.
Improve visibility of EPHA messages: appear more frequently appear in high-level media and increase social media reach, better access target audiences.
Details
Start date: 01/01/2016
End date: 31/12/2016
Duration: 12 month(s)
Current status: Finalised
Programme title: 3rd Health Programme (2014-2020)
EC Contribution: € 661 956,00
Keywords: Amr, Anthrax, Anthrax, Blood, Botulism, Breast, Brucellosis, Campylobacteriosis, Cancer, Cardiovascular Diseases, Cervical, Chlamydia, Cholera, Chronic Diseases, Chronic Diseases, Chronic kidney diseases, Chronic pulmonary diseases, Colorectal, Communicable Diseases, Communicable Diseases, Cryptosporidiosis, Dengue fever, Diabetes, Diphtheria, Diseases of zoonotic and environmental origin and vector borne, E, E/M-Health, Echinococcosis, Economic Policy, Emergent pathogens, Epilepsy, Food and waterborne diseases, Giardisasis, Gonorrhea, HIV, STIs & Blood borne infections, Health Research, Healthcare-associated infections, Hepatitis A, Hepatitis B, Hepatitis C, Hiap, Hiv/Aids, Hpv, Hspa, Hspa., Influenza, Invasive Haemophilus influenzae disease, Invasive pneumococcal disease, Ischaemic heart disease, Legionnaire's diseaese, Leptospirosis, Leptospirosis, Listeriosis, Lung, M-Health, Malaria, Measles, Menongoccal disease, Multiple sclerosis, Mumps, Musculo skeletal conditions, Ncds, Neurological diseases and disorders, Other specific diseases, Parkinson's disease, Participation, Plague, Polio, Prevention, Prevention, Promotion, Protection, Public Health, Qfever, Rabies, Respiratory tract infections, Rubella, SARS, Salmonellosis, Shigellosis, Shigellosis, Smallpox, Stomach, Stroke, Syphilis, Tetanus, Toxoplasmosis, Trade, Trichinellosis, Tuberculosis, Tularaemia, Tularemia, Type I, Typhoid fever, Universal Access, VTEC, Vaccine-preventable diseases, Variant Creutzfeld-Jakob disease, Viral Haemorrhagic fevers, West Nile fever, Yellow fever, Yersiniosis, campylobacteriosis, pertussis, prostate, salmonellosis, skin, type II
Portfolio: Interest groups